Table 1 Direct medical cost of Parkinson’s disease by age, gender, insurance coverage, and types of service (in 2017 $s).

From: Current and projected future economic burden of Parkinson’s disease in the U.S.

 

Total excess medical cost due to PD

Per PWP ($)

(in Million $s)

Percentage of the total

Age

 ≤49

490

2%

29,346

 50–64

4,153

16%

22,598

 65–74

8,858

35%

23,011

 ≥75

11,847

47%

26,222

Gender

 Male

13,580

54%

22,838

 Female

11,768

46%

26,589

Insurance

 Private

1,742

7%

22,671

 Medicare

22,793

90%

24,811

 Othera

812

3%

19,489

Type of service

 Non-acute institutional care

7,144

28.2%

6,888

 Hospital inpatient

7,190

28.4%

6,932

 Outpatient

5,506

21.7%

5,308

 Physician office

1,226

4.8%

1,182

 Durable medical equipment

145

0.6%

140

 Prescription medication

4,137

16.3%

3,988

Overall

25,348

100%

24,439

  1. Source: Authors’ estimation of PD prevalence using 2011–2015 Medical Expenditure Panel Survey (MEPS), 2015 Medicare Current Beneficiary Survey (MCBS), and Census population projections for 2017; combined with direct medical cost estimated using 2016 Optum claims data, 2015 Medicare Standard Analytical File 5% sample claims, and 2015 MCBS.
  2. aOther includes Medicaid, other insurance, and uninsured. Sample size in MEPS did not support further breakdown.
Back to article page